Listing Of Guangdong Pharma Could Be Delayed Over Wanglaoji Dispute
This article was originally published in PharmAsia News
Executive Summary
Guangzhou Pharmaceutical Co., Ltd. has been embroiled in a closed-door arbitration case with Hung To (Holdings) Co., Ltd. over the lease of the Wanglaoji trademark, which could potentially delay GP’s integrated listing plan.